PBE icon

Invesco Biotechnology & Genome ETF

89 hedge funds and large institutions have $63M invested in Invesco Biotechnology & Genome ETF in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 27 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
Holders Change %
0%
% of All Funds
1.5%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
9
Reduced
27
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
HWMA
76
Heritage Wealth Management (Arizona)
Arizona
$8.66K
HI
77
Harbour Investments
Wisconsin
$8K +$8K +146 New
RF
78
Robbins Farley
New Hampshire
$7K +$960 +17 +16%
SCA
79
Stonebridge Capital Advisors
Minnesota
$6K
TSWM
80
Tyler-Stone Wealth Management
Ohio
$4K
BBPWM
81
Blue Bell Private Wealth Management
Pennsylvania
$3K
ARMC
82
American Research & Management Company
Massachusetts
$3K
AIP
83
Ameritas Investment Partners
Nebraska
$2K
WWM
84
Wagner Wealth Management
South Carolina
$1K -$6K -120 -86%
BFEC
85
Benjamin F. Edwards & Company
Missouri
$1K -$500 -5 -33%
BAM
86
Baldrige Asset Management
Pennsylvania
$1K
BCMLT
87
Beacon Capital Management LLC (Tennessee)
Tennessee
$1K
M&T Bank
88
M&T Bank
New York
$1K +$1K +20,075 New
Bank of Montreal
89
Bank of Montreal
Ontario, Canada
$49 -$3 -57 -6%
Susquehanna International Group
90
Susquehanna International Group
Pennsylvania
-$707K -11,405 Closed
BCM
91
Beck Capital Management
Texas
-$292K -4,714 Closed
AWS
92
Atria Wealth Solutions
New York
-$221K -3,569 Closed
Neuberger Berman Group
93
Neuberger Berman Group
New York
-$217K -3,495 Closed
Koshinski Asset Management
94
Koshinski Asset Management
Illinois
-$102K -1,640 Closed
Creative Planning
95
Creative Planning
Kansas
-$19K -300 Closed